Showing results (1-10 of 77) with videos related to
Sort By:
Pageof 8
Cancer Journal (Sudbury, Mass.)|June 27, 2009
Recent advances using anti-CTLA-4 for the treatment of melanomaAmod A Sarnaik, Jeffrey S WeberCurrent Oncology Reports|August 21, 2007
Multidisciplinary management of special melanoma situations: oligometastatic disease and bulky nodal sitesAmod A Sarnaik, Jonathan S Zager, Vernon K SondakOncoimmunology|November 21, 2015
Triggering co-stimulation directly in melanoma tumor fragments drives CD8+ tumor-infiltrating lymphocyte expansion with improved effector-memory propertiesJessica Ann Chacon, Amod A Sarnaik, Shari Pilon-Thomas, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 27, 2012
Blockade of myeloid-derived suppressor cells after induction of lymphopenia improves adoptive T cell therapy in a murine model of melanomaKrithika N Kodumudi, Amy Weber, Amod A Sarnaik, et al.Cancer Cell|July 19, 2024
Tumor-infiltrating lymphocytes: A new hopeAmod A Sarnaik, Patrick Hwu, James J Mulé, et al.Cancer Control : Journal of the Moffitt Cancer Center|June 27, 2009
Limiting the morbidity of inguinal lymphadenectomy for metastatic melanomaAmod A Sarnaik, Christopher A Puleo, Jonathan S Zager, et al.Surgical Oncology Clinics of North America|May 14, 2019
Current Immunotherapy Practices in MelanomaLuke D Rothermel, Amod A Sarnaik, Nikhil I Khushalani, et al.Surgical Oncology Clinics of North America|October 22, 2003
Technology of intraperitoneal chemotherapy administration: a survey of techniques with a review of morbidity and mortalityAmod A Sarnaik, Jeffrey J Sussman, Syed A Ahmad, et al.Oncoimmunology|December 10, 2013
Continuous 4-1BB co-stimulatory signals for the optimal expansion of tumor-infiltrating lymphocytes for adoptive T-cell therapyJessica Ann Chacon, Shari Pilon-Thomas, Amod A Sarnaik, et al.Cancer Control : Journal of the Moffitt Cancer Center|January 11, 2013
Immunotherapy for gastrointestinal malignanciesPaul G Toomey, Nasreen A Vohra, Tomar Ghansah, et al.Pageof 8